Family Care Hospitals trading window shut for Q1 FY27

What the company announced

Family Care Hospitals Ltd has announced the closure of its trading window for dealing in the company’s securities. The restriction will start from Wednesday, July 1, 2026. It will remain in force until 48 hours after the declaration of the un-audited financial results for the first quarter ended June 30, 2026. The disclosure applies to designated persons and their immediate relatives, who are prohibited from trading during the closure period.

The company said the board meeting date to approve the un-audited Q1 results will be communicated separately. Trading window closures are typically implemented under insider trading compliance rules, especially around results announcements. For investors, the update is mainly procedural, but it also sets expectations that quarterly numbers will be released after the board meeting is scheduled and held.

Link to earlier results disclosure for June 2025 quarter

The same set of information also references an earlier announcement: unaudited financial results for the quarter ended June 30, 2025, along with a limited review report. While the detailed numbers for that June 2025 quarter are shown later through multiple summaries, the key point is that the company has been publishing quarterly financial disclosures and limited review reports as part of its compliance.

Separately, data points cited for June 2025 indicate standalone net sales of ₹0.02 crore, with references to year-on-year comparisons. The information also mentions standalone March 2025 net sales at ₹0.02 crore and standalone March 2026 net sales at ₹0.06 crore.

Stock price and market snapshot around June 2026

On June 3, 2026, Family Care Hospitals was reported at ₹3.23, up 0.31% compared with its previous close of ₹3.22. At that time, the market capitalisation was stated at ₹17.44 crore. Another snapshot shows the share price at ₹2.9 as of June 28, 2026, after opening at ₹3 and closing at ₹3 the previous day. During that session, the price moved between ₹2.92 and ₹3.04, with an average price of ₹2.98.

Over the last 52 weeks, the stock recorded a low of ₹2.55 and a high of ₹5.83. Performance figures cited include a decline of 20.2% over the past six months and a decline of 33.86% over the last year. Another data point reports the price at ₹3.69, up 8.53% for the day, with the 52-week range again shown as ₹2.55 to ₹5.83.

Q1 quarterly snapshot: June 2025 (standalone)

A quarterly table (figures in ₹ crore) provides a snapshot for the quarter ended June 2025. Total revenue for the period is shown as ₹0.02 crore, compared with ₹0.06 crore in March 2026 on a quarter-on-quarter comparison. Total operating expense for June 2025 is ₹0.64 crore, and depreciation and amortisation is ₹0.23 crore.

Operating income is reported at -₹0.62 crore for June 2025, while net income is reported at -₹0.70 crore. The table also lists selling, general and administrative expenses at ₹0.11 crore for the quarter. Diluted normalised EPS is shown at -₹0.13 for June 2025.

FY26 audited results: sharp fall in operations, losses continue

Family Care Hospitals reported audited standalone financial results for FY26, posting a net loss of ₹8.6829 crore on revenue from operations of ₹0.2097 crore. The audited results for the quarter and year ended March 31, 2026 were approved by the board at a meeting held on May 12, 2026.

The company’s FY26 net loss of ₹8.6829 crore compared with a net loss of ₹44.1453 crore in FY25. Total income for FY26 stood at ₹0.4502 crore, significantly lower than ₹11.0568 crore in the previous year. These figures show that both operating revenue and total income were substantially lower in FY26 than in FY25, while the company still reported a sizeable annual loss.

Q4 FY26 versus earlier quarters: income trends in ₹ crore

For Q4 FY26 (audited), the company reported revenue from operations of ₹0.0586 crore and other income of ₹0.1082 crore, taking total income to ₹0.1668 crore. In Q3 FY26 (unaudited), revenue from operations is shown at ₹0.0601 crore, other income at ₹0.0281 crore, and total income at ₹0.0882 crore. For Q4 FY25 (audited), revenue from operations was ₹0.0243 crore, other income was ₹2.0276 crore, and total income was ₹2.0519 crore.

Basic and diluted EPS (₹) is listed at (0.45) for Q4 FY26 and (1.61) for FY26, versus (8.17) for FY25. These EPS figures, alongside the income numbers, highlight that the company has remained loss-making across the reported periods.

Other quarterly data points cited in the disclosures

A separate quarterly result table (figures in ₹ crore) lists net sales of ₹0.02 crore for June 2025, ₹0.02 crore for March 2025, and ₹0.03 crore for December 2024. It also shows net sales of ₹0.07 crore for September 2025 and ₹0.06 crore for December 2025. The same table reports operating profit as negative across the listed quarters, including -₹0.39 crore for June 2025 and -₹4.39 crore for September 2025.

In another section, Q2 FY2026 revenue is shown as ₹0.18 crore, with net profit at -₹4.61 crore, and Q1 FY2026 revenue is shown as ₹0.02 crore, with net profit at -₹0.70 crore. These are presented as summary metrics, alongside operating profit margin values.

Key figures table

Market impact: what investors can track next

The trading window closure itself does not change business performance, but it signals that results approval is pending and that the company will set a board meeting date for Q1 numbers. For a stock that has moved within a 52-week band of ₹2.55 to ₹5.83, results updates can matter because reported revenues and losses have been volatile and, in FY26, small in absolute terms.

Recent market data cited shows mixed short-term moves, including a day when the stock was up 0.31% at ₹3.23 and another snapshot where it rose 8.53% to ₹3.69. At the same time, the stock has been reported to be down 20.2% over six months and down 33.86% over one year. Investors typically watch whether quarterly revenue from operations improves meaningfully from the low base seen in FY26, and whether losses narrow in line with changes in operating expenses and other income.

Why the FY26 numbers matter ahead of Q1 FY27

FY26 audited results show revenue from operations of ₹0.2097 crore against a net loss of ₹8.6829 crore, alongside total income of ₹0.4502 crore. This gap between income and losses makes upcoming quarterly disclosures important for assessing whether operating performance is stabilising, whether cost structures are changing, and how much of reported income is coming from other income.

The company has also reported quarter-level shifts in total income across FY26, including Q4 total income of ₹0.1668 crore versus Q3 total income of ₹0.0882 crore. With the trading window shut from July 1, 2026, the next formal milestone is the board meeting date, after which the un-audited Q1 results for the quarter ended June 30, 2026 are expected to be released.

Conclusion

Family Care Hospitals’ trading window will remain closed from July 1, 2026 until 48 hours after the declaration of un-audited Q1 results for the quarter ended June 30, 2026, with the board meeting date to be announced separately. The update comes after FY26 audited results showed revenue from operations of ₹0.2097 crore and a net loss of ₹8.6829 crore. Investors will likely focus on the timing of the board meeting and the detailed quarterly financials once they are disclosed.